↓ Skip to main content

Cochrane Database of Systematic Reviews

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

Overview of attention for article published in Cochrane database of systematic reviews, January 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
143 Mendeley
citeulike
1 CiteULike
Title
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C
Published in
Cochrane database of systematic reviews, January 2013
DOI 10.1002/14651858.cd003617.pub2
Pubmed ID
Authors

Ronald L Koretz, Maria Pleguezuelo, Vasiliki Arvaniti, Pilar Barrera Baena, Ruben Ciria, Kurinchi Selvan Gurusamy, Brian R Davidson, Andrew K Burroughs

Abstract

The widely-accepted treatment outcome for chronic hepatitis C is the sustained viral response (that is, no measurable viral RNA in blood six months after treatment). However, this surrogate outcome (as well as the previously employed biochemical and histologic ones) has never been validated. This situation exists because there are very few randomized clinical trials that have used clinical events (mortality or manifestations of decompensated cirrhosis) as outcomes, because those clinical events only occur after many years of infection. Patients in whom initial therapy fails to produce sustained viral responses do become potential candidates for retreatment; some of these individuals are not candidates for ribavirin or protease inhibitors and consideration could be given to retreatment with interferon alone.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 1%
United Kingdom 1 <1%
Brazil 1 <1%
Unknown 139 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 18%
Researcher 18 13%
Student > Bachelor 17 12%
Student > Ph. D. Student 14 10%
Other 12 8%
Other 31 22%
Unknown 25 17%
Readers by discipline Count As %
Medicine and Dentistry 70 49%
Nursing and Health Professions 9 6%
Psychology 5 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Agricultural and Biological Sciences 4 3%
Other 18 13%
Unknown 32 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 February 2016.
All research outputs
#1,434,626
of 17,826,855 outputs
Outputs from Cochrane database of systematic reviews
#3,589
of 11,769 outputs
Outputs of similar age
#19,249
of 255,728 outputs
Outputs of similar age from Cochrane database of systematic reviews
#174
of 470 outputs
Altmetric has tracked 17,826,855 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,769 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.3. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 255,728 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 470 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.